Maravai LifeSciences Holdings, Inc.
MRVI
$2.45
$0.062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.00% | -25.85% | -23.54% | -1,023.56% | -277.88% |
| Total Depreciation and Amortization | 8.25% | 12.39% | 16.57% | 20.70% | 27.51% |
| Total Amortization of Deferred Charges | -23.64% | -11.29% | -1.13% | 4.96% | 4.92% |
| Total Other Non-Cash Items | 8.51% | 14.50% | 8.09% | 200.40% | -22.91% |
| Change in Net Operating Assets | -62.70% | -60.53% | -108.88% | -95.35% | -89.41% |
| Cash from Operations | -168.42% | -79.98% | -94.09% | -86.27% | -90.14% |
| Capital Expenditure | 52.87% | 53.86% | 54.76% | 26.12% | -4.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -17,189.91% | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -85.73% | -27.46% | -58.48% | 359.68% | 356.19% |
| Cash from Investing | -3.62% | 23.97% | 80.12% | 74.76% | 67.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,819.04% | -3,872.69% | -3,971.83% | -7.19% | -8.95% |
| Issuance of Common Stock | -95.83% | -- | -- | -- | -78.44% |
| Repurchase of Common Stock | -195.42% | -201.63% | -204.39% | -449.85% | -444.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -127.60% | 98.42% | 100.80% | 107.18% | 105.21% |
| Cash from Financing | -26,355.59% | -465.61% | -285.84% | 100.74% | 100.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,229.25% | -315.48% | -341.73% | 96.17% | -123.75% |